CoChat

Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study

Behan, L A, Sherlock, M, Moyles, P, Renshaw, O, Thompson, C J T, Orr, C, Holte, K, Salehmohamed, M R, Glynn, N, Tormey, W, Thompson, C J · 2015 · European Journal of Endocrinology

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Context and objective: Patients with cranial diabetes insipidus (CDI) are at risk of developing both hypernatraemia and hyponatraemia, due to the condition itself or secondary to treatment with vasopressin-analogues or during administration of i.v. fluids. We aimed to assess the frequency and impact of dysnatraemias in the inpatient (INPT) and outpatient (OPT) setting in desmopressin-treated CDI, comparing those with normal thirst with those with abnormal thirst. Design: The study included 192 patients with cranial diabetes, who were identified from the Beaumont Pituitary Database, a tertiary referral centre. Retrospective case note audit was performed and the clinical and biochemical information of 147 patients with CDI were available for analysis. Results: A total of 4142 plasma sodium measurements for 137 patients with normal thirst, and 385 plasma sodium measurements for ten patients with abnormal thirst were analysed. In those with normal thirst, the most common OPT abnormality was mild hyponatraemia (pNa+131–134 mmol/l) in 27%, while 14.6% had more significant hyponatraemia (pNa+≤130 mmol/l). Of those patients with normal thirst, 5.8% were admitted due to complications directly related to hyponatraemia. Compared with patients with normal thirst, those with abnormal thirst were more likely to develop significant OPT hypernatraemia (20% vs 1.4%,P=0.02) and significant INPT hyponatraemia (50% vs 11.1%,P 0.02). Conclusion: OPT management of CDI is complicated by a significant incidence of hyponatraemia. In contrast, OPT hypernatraemia is almost exclusively a complication seen in adipsic CDI, who also had more frequent INPT hyponatraemia. CDI associated with thirst disorder requires increased physician attention and patient awareness of potential complications.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-14-0719

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 3

  1. THOMPSON, 1987, QJM, 65, 853
  2. 1987, American Journal of Physiology -- Legacy Content, 252, R1138
  3. 1986, American Journal of Physiology -- Legacy Content, 251, R214

Cited by

See all 79

Metadata

Authors
Behan, L. A., Sherlock, M., Moyles, P., Renshaw, O., Thompson, C. J. T., Orr, C., Holte, K., Salehmohamed, M. R., Glynn, N., Tormey, W., & Thompson, C. J.
Affiliations
  • Beaumont Hospital (IE)
  • Trinity College Dublin (IE)
  • Royal College of Surgeons in Ireland (IE)
Corresponding author
Thompson, C J
Venue
European Journal of Endocrinology
Published
2015-03
Volume
172
Issue
3
Pages
243-250
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2036109669
Cited by
75
References
20
Citations by year
2026: 7 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 4 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 4
FWCI
2.67
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
central diabetes insipidus, desmopressin, hyponatremia, hypernatremia, plasma sodium, outpatient management, hospitalization
MeSH terms
Adult, Deamino Arginine Vasopressin, Diabetes Insipidus, Female, Humans, Hypernatremia, Hyponatremia, Male, Middle Aged, Retrospective Studies, Sodium, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study. https://app.cochat.ai/papers/10.1530/eje-14-0719
The paper
Behan, L. A., Sherlock, M., Moyles, P., Renshaw, O., Thompson, C. J. T., Orr, C., Holte, K., Salehmohamed, M. R., Glynn, N., Tormey, W., & Thompson, C. J. (2015). Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study. European Journal of Endocrinology. https://doi.org/10.1530/eje-14-0719

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.